Gedeon Richter: Cariprazine shows effectiveness in the treatment for dual disorder

In addition, Richter organized two scientific sessions: the Product Theatre focused on the topic of "New treatment options for dual schizophrenia", and a Mini Symposium was organized on the topic of "Schizophrenia and the management of psychiatric comorbidities", such as affective, anxiety and substance use disorders. In addition, Richter organized two scientific sessions: the Product Theatre focused on the topic of " New treatment options for dual schizophrenia ", and a Mini Symposium was...
BUDAPEST, Hungary, (informazione.it - comunicati stampa - salute e benessere)

In addition, Richter organized two scientific sessions: the Product Theatre focused on the topic of "New treatment options for dual schizophrenia", and a Mini Symposium was organized on the topic of "Schizophrenia and the management of psychiatric comorbidities", such as affective, anxiety and substance use disorders.

On the 7th of April, during a Scientific Event involving over 250 doctors, Professor Christoph U. Correll highlighted the importance of using measurements in everyday psychiatric practice, and experts from Gedeon Richter launched a new transdiagnostic tool for quantifying, and visualizing symptom severity and functional disability of patients with different psychiatric conditions which is available online. During the time of the conference, Richter's Candid Book – a comprehensive summary of important topics that responds to caregivers' needs in real life situations – was also presented to the professional audience.

About Richter  

About Cariprazine

Cision View original content:https://www.prnewswire.co.uk/news-releases/gedeon-richter-cariprazine-shows-effectiveness-in-the-treatment-for-dual-disorder-302115698.html

Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Slide ShowSlide Show
Non disponibili